The current study investigates the influence of auditory cues on the localization of briefly presented peripheral visual stimuli. Because the brief presentation of peripheral visual stimuli often leads to mislocalization (Binda, Morrone, & Burr, 2010; Bocianski, Musseler, & Erlhagen, 2008; Musseler, Heijden, Mahmud, Dubel, & Ertsey, 1999) these types of stimuli are the most commonly studied and represent the basis of the current study. Musseler et al. (1999) found that peripheral mislocalization toward the fovea occurred during asynchronous presentations of a pair of visual stimuli in retinal periphery, but not during synchronous presentations of stimuli. The current project is an investigation of how sound influences mislocalization of briefly presented peripheral stimuli. If the mechanism of mislocalization is an increased variability of responses when the peripheral stimuli are presented asynchronously, could sound reduce the variability of localization judgments and thus, reduce or eliminate the mislocalization effect? Does sound influence peripheral mislocalization in some other way? This study found that during a relative judgment task, a brief, laterally presented sound leads to mislocalization of a target stimulus toward the direction of the sound (Experiment 1). During an absolute judgment task, however, the influence of the brief, laterally presented sound no longer evokes mislocalization in the direction of the sound. Rather, stimulus onset asynchrony elicits mislocalization similar to the results of Musseler et al. (Experiment 2). When a dynamic sound stimulus occurs prior to the onset of the target stimulus during an absolute judgment task, however, sound idiosyncratically influences the localization of a target stimulus toward the onset of the sound stimulus or direction of the apparent motion of the sound stimulus (Experiment 3).

RNA localization, a regulated step of gene expression, is fundamentally important in development and differentiation. In multidisciplinary experiments, we discovered that RNA (mis)localization underlies the human disease myotonic dystrophy (DM). DM, the most prevalent adult muscular dystrophy, is caused independently by two alleles: DM1 is characterized by a (CTG)n expansion in the DM kinase (DMPK) gene 3' untranslated region while DM2 has a mutation in a small presumptive RNA binding protein. These analyses were guided by disease characteristics and have provided insights to DM's cytopathology, cell biology and molecular genetics. Examining muscle biopsies, it is demonstrated here that DM kinase mRNA is specifically subcellularly localized within normal human muscle and that DM kinase mRNA harboring the 3’UTR mutation (DM1) is mislocalized in DM patient muscle to cytoplasmic areas characteristic of DM disease pathology. Thus, the disease mutation alters the cellular distribution of the effected message. DMPK mRNA mislocalization causes altered DM kinase protein localization, correlates with novel phosphoprotein appearance and can account for DM’s diseased phenotype. While we were fortunate to access DM patient tissue to establish these key findings, the system does not lend itself to experimental manipulation. Hence, I established a disease- relevant tissue culture system, which recapitulates DMPK trafficking, Employing this system; I elucidate a complementary role for the DM2 gene product as a localization factor for DMPK mRNA (DM1 gene product). Comprehensive RNA-protein interaction experiments reveal the DM2 protein specifically and selectively recognizes a small, definitive area within the DMPK RNA 3'UTR. Detailed biochemical, cytological and functional experiments reveal 1) the DM2 protein colocalizes with DMPK mRNA, 2) the small area of the DMPK 3’UTR bound by pDM2 acts to properly localize a reporter construct and 3) disruption of the DM2 protein results in DMPK mRNA mislocalization. These data establish mRNA localization as a vital process underlying human disease etiology. Moreover, they reveal DM1 and DM2 gene products function in the same molecular pathway and that mutation of either causes DMPK mRNA mislocalization, leading to disease. These data have apparent application to several neuromuscular disorders and open a plethora of novel research avenues, both basic and applied. / text

No / Motion is known to distort visual space, producing illusory mislocalizations for flashed objects. Previously, it has been shown that when a stationary bar is flashed in the proximity of a moving stimulus, the position of the flashed bar appears to be shifted in the direction of nearby motion. A model consisting of predictive projections from the sub-system that processes motion information onto the sub-system that processes position information can explain this illusory position shift of a stationary flashed bar in the direction of motion. Based on this model of motion¿position interactions, we predict that the perceived position of a flashed stimulus should also be attracted towards a nearby moving stimulus. In the first experiment, observers judged the perceived vertical position of a flash with respect to two horizontally moving dots of unequal contrast. The results of this experiment were in agreement with our prediction of attraction towards the high contrast dot. We obtained similar findings when the moving dots were replaced by drifting gratings of unequal contrast. In control experiments, we found that neither attention nor eye movements can account for this illusion. We propose that the visual system uses predictive influences from the motion processing sub-system on the position processing sub-system to overcome the temporal limitations of the position processing system.

La sclérose latérale amyotrophique (SLA) et la démence fronto-temporale (DFT) sont deux maladies qui constituent un continuum clinico-pathologique. La mutation de FUS, une protéine nucléaire à fonctions multiples, provoque des cas familaux de SLA, et ces mutations provoquent une redistribution sub-cellulaire de FUS, du noyau vers le cytoplasme. Certains cas de DFT présentent une telles distribution anormale en l’absence de mutations de FUS. Il n’est pas connu si la maladie est provoquée par une perte de la fonction nucléaire de FUS et/ou un gain de fonction cytoplasmique.Nous avons généré et caractérisé une lignée de souris exprimant une forme cytoplasmique de FUS (Fus-ΔNLS). La localisation exclusive de FUS dans le cytoplasme provoque la mort des motoneurones via un gain de fonction dans les motoneurones eux-mêmes. Une localisation cytoplasmique partielle de FUS est suffisante pour développer un phénotype de la SLA et de DFT. Les mécanismes élucidés permettront de comprendre les bases des SLA/DFT. / Amyotrophic lateral sclerosis (ALS) and Frontotemporal dementia (FTLD) are now considered as a unique clinicopathological spectrum referred to as ALS/FTLD. Cytoplasmic aggregation of the physiologically nuclear FUS protein is a hallmark feature of a subset of ALS/FTLD. It remains unknonwn whether the critical pathogenic event relies on a loss of FUS normal nuclear functions, a toxic gain of function of FUS in the cytoplasm, or a combination of both.To answer this question we have generated a conditional mouse model expressing truncated FUS without nuclear localization signal - FusΔNLS. Our data showed that complete cytoplasmic mislocalization of truncated FUS protein within spinal motor neurons is a major determinant of motor neuron degeneration via toxic gain of function. A partial mislocalization of truncated FUS protein was sufficient to trigger key features of ALS and of FTLD.These studies allowed the elucidation of mechanisms underlying FUS role in ALS/FTLD, and will hopefully lead to development of therapies for these devastating diseases.